Elevated serum cortisol associated with early-detected increase of brain amyloid deposition in Alzheimer’s disease imaging biomarkers among menopausal women: The Framingham Heart Study.

This study investigates whether midlife cortisol levels predict Alzheimer’s disease (AD) biomarker burden 15 years later, with particular attention to sex differences and menopausal status.